New Zealand markets open in 3 hours 13 minutes

ResMed Inc. (RMD)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
215.66-0.06 (-0.03%)
As of 02:47PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 31.56B
Enterprise value 32.19B
Trailing P/E 40.70
Forward P/E 34.25
PEG ratio (5-yr expected) 3.10
Price/sales (ttm)8.95
Price/book (mrq)9.62
Enterprise value/revenue 9.09
Enterprise value/EBITDA 27.36

Trading information

Stock price history

Beta (5Y monthly) 0.45
52-week change 3-12.99%
S&P500 52-week change 3-11.93%
52-week high 3301.34
52-week low 3189.40
50-day moving average 3205.23
200-day moving average 3240.39

Share statistics

Avg vol (3-month) 3600.1k
Avg vol (10-day) 3805.62k
Shares outstanding 5146.28M
Implied shares outstanding 6N/A
Float 8144.95M
% held by insiders 10.81%
% held by institutions 168.42%
Shares short (14 Jun 2022) 41.5M
Short ratio (14 Jun 2022) 42.84
Short % of float (14 Jun 2022) 41.15%
Short % of shares outstanding (14 Jun 2022) 41.02%
Shares short (prior month 12 May 2022) 41.36M

Dividends & splits

Forward annual dividend rate 41.68
Forward annual dividend yield 40.78%
Trailing annual dividend rate 31.68
Trailing annual dividend yield 30.78%
5-year average dividend yield 41.07
Payout ratio 431.13%
Dividend date 315 Jun 2022
Ex-dividend date 410 May 2022
Last split factor 22:1
Last split date 330 Aug 2010

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 22.02%
Operating margin (ttm)27.87%

Management effectiveness

Return on assets (ttm)12.99%
Return on equity (ttm)26.03%

Income statement

Revenue (ttm)3.54B
Revenue per share (ttm)24.26
Quarterly revenue growth (yoy)12.50%
Gross profit (ttm)1.89B
EBITDA 1.1B
Net income avi to common (ttm)779.48M
Diluted EPS (ttm)5.30
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)219.61M
Total cash per share (mrq)1.5
Total debt (mrq)832.09M
Total debt/equity (mrq)25.38
Current ratio (mrq)2.55
Book value per share (mrq)22.42

Cash flow statement

Operating cash flow (ttm)498.19M
Levered free cash flow (ttm)219.56M